Flora Peyvandi/X, Wolfgang Miesbach/LinkedIn
Sep 8, 2026, 15:57
Flora Peyvandi: Efficiency Meets Innovation in Hemophilia B Gene Therapy
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of ISTH, shared on X about a recent article by Wolfgang Miesbach, published in Blood Advances, adding:
”Doing more with less in hemophilia B gene therapy | Blood Advances | American Society of Hematology.”
Title: Doing more with less in hemophilia B gene therapy
Author: Wolfgang Miesbach
Other posts featuring Flora Peyvandi on Hemostasis Today.
-
Sep 26, 2026, 09:49Manuel Monreal: Acute VTE in Patients With Severe Renal Insufficiency
-
Sep 26, 2026, 09:38New TIF Guidelines for Emergency Care in Thalassaemia and SCD
-
Sep 26, 2026, 09:28Annette Bowyer: Rethinking Product Specific Calibrators in Haemophilia
-
Sep 26, 2026, 09:21Nisanth Menon: When Emergency Medicine Meets Transfusion Medicine
-
Sep 26, 2026, 07:50Giuseppe Andò: P2Y12 Inhibition in Diabetes – A Personalized Approach
-
Sep 26, 2026, 07:36Tiffany Hall: Honored to Be Recognized for Advancing Blood Health
-
Sep 26, 2026, 07:23Jignesh Patel: Call for Papers on Safer IV Unfractionated Heparin Use
-
Sep 26, 2026, 07:13Denise Braendgaard: OneSCD Brings Sickle Cell Disease to the Global Stage
-
Sep 26, 2026, 07:03Robert Tadevosyan: From Scientific Day to the Stago Factory